Lyra Therapeutics, Inc. (LYRA) Shareholders’ equity 2021–2025
Lyra Therapeutics, Inc. (LYRA) shareholders’ equity at each fiscal year-end, per SEC filings.
-$10.7MFY2025 · since FY2021: $34.3M → -$10.7M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$10.7M | -192.4% |
| FY2024 | $11.6M | -87.0% |
| FY2023 | $89.4M | +10.7% |
| FY2022 | $80.8M | +135.3% |
| FY2021 | $34.3M | — |
Source: SEC XBRL filings · For reference only · Not investment advice